Long Term Outcomes of BRCA1/BRCA2 Mutation Testing

Abstract

This project aims to gain a better understanding of the implications of genetic testing for breast-ovarian cancer susceptibility. The primary goal is to evaluate the impact of BRCA1/BRCA2 mutation testing on long term psychosocial (quality of life, distress, social functioning) and prevention/surveillance (mammography, CA125, transvaginal ultrasound, prophylactic mastectomy, prophylactic oophorectomy and chemoprevention) outcomes. To accomplish this we will measure outcomes within a group of women who received BRCA1/BRCA2 test results at least four years ago. We will divide our sample based upon their personal cancer history - evaluating cancer survivors with different measures compared to unaffected individuals. For both survivors and unaffected individuals we will recruit separate comparison samples of women who have never received BRCA1/BRCA2 testing.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Aug 01, 2008
Accession Number
ADA520553

Entities

People

  • Marc D. Schwartz

Organizations

  • Georgetown University

Tags

DTIC Thesaurus Topics

  • Biomedical Research
  • Breast Cancer
  • Cancer
  • Data Analysis
  • Department Of Defense
  • Drug Therapy
  • Families (Human)
  • Genetic Testing
  • Mammography
  • Mastectomy
  • Mutations
  • Neoplasms
  • Ovarian Cancer
  • Quality Of Life
  • Social Psychology
  • Surgery
  • Surveillance

Readers

  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.

Technology Areas

  • Biotechnology